Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

PRP therapy improves hair density and thickness in AGA patients, even with other treatments.

Women with AGA have higher lipid levels, increasing heart disease risk.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

Misdiagnosis of LPP in AGA patients can cause hair transplant issues.

Some people's hair loss is caused by multiple factors, with the most common being a mix of AGA and CCCA.

AGA progression involves increased lipid synthesis, electron transport, and hair follicle miniaturization.

AGA affects many, progresses differently, and early treatment is crucial.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Higher DHT in male baldness may protect against prostate cancer.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

AGA linked to inflammation, stress, fibrosis, and disturbed hair follicle stem cells.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

AGA patients have higher heart disease risk.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Hair density and thickness decrease in all scalp areas for East Asians with AGA.

SA linked to mitochondrial issues and oxidative stress, while AGA involves disrupted hair growth genes.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

AGA might indicate higher risk for severe COVID-19.

PRP treatment improves hair count, density, and reduces hair loss in AGA patients.

People with androgenetic alopecia (AGA) have lower hair density and more single-hair units compared to those with normal scalps.

AGA causes hair loss through follicle miniaturization and hair cycle changes; regrowth depends on anagen initiation in kenogen follicles.

AGA treated with finasteride, minoxidil, and hair transplantation.

Reducing micro-inflammation didn't change hair growth patterns in AGA.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Adipose stem cell-derived exosomes are safe and effective for hair regrowth in AGA patients.

Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.